---
figid: PMC9103778__nutrients-14-01859-g005
pmcid: PMC9103778
image_filename: nutrients-14-01859-g005.jpg
figure_link: /pmc/articles/PMC9103778/figure/nutrients-14-01859-f005/
number: Figure 5
figure_title: ''
caption: 'Effect of MON on the AKT/mTOR/FOXO3a signaling pathway in DEX-treated mice.
  The phosphorylation of mTOR, FOXO3a, and AKT was determined by Western blot (A).
  MON increased expression of phosphorylation of each protein in in gastrocnemius
  tissues of mice (B–D). Each value is the mean ± SD of three independent experiments.
  ## p < 0.01, ### p < 0.001 vs. Nor; * p < 0.05, ** p < 0.01 and *** p < 0.001 vs.
  DEX. Nor, normal group; DEX, dexamethasone-treated group; and MON, monotropein-administrated
  group.'
article_title: Monotropein Improves Dexamethasone-Induced Muscle Atrophy via the AKT/mTOR/FOXO3a
  Signaling Pathways.
citation: Piao Wang, et al. Nutrients. 2022 May;14(9):1859.
year: '2022'

doi: 10.3390/nu14091859
journal_title: Nutrients
journal_nlm_ta: Nutrients
publisher_name: MDPI

keywords:
- AKT/mTOR/FOXO3a signaling pathways
- Atrogin1
- muscle atrophy
- monotropein
- dexamethasone
- MuRF1

---
